Table 1.
All | 1-kb deletion | ||
---|---|---|---|
Homozygous | Non-homozygousa | ||
Age at enrolment, n | 20 | 10 | 10 |
Median (years) | 10.7 | 12.3 | 10.7 |
Quartiles [1st;3rd] | [7.8;15.6] | [8.2;16.0] | [8.1;12.9] |
Range [min;max] | [6.8;20.7] | [6.8;16.6] | [6.8;20.7] |
Sex, n | 20 | 10 | 10 |
Females | 10 | 6 | 4 |
Seizure, n | 14 | 8 | 6 |
Age at onset | |||
Median (years) | 10.0 | 8.0 | 12.0 |
Quartiles [1st;3rd] | [6.3;13.0] | [6.0;11.5] | [8.8;13.0] |
Range [min;max] | [5;16] | [6;13.5] | [5;16] |
Semiologyb, n | |||
Tonic-clonic | 11 | 6 | 5 |
Nonmotor | 7 | 5 | 2 |
Focal motor | 1 | 1 | 0 |
Myoclonic | 1 | 0 | 1 |
Tonic | 1 | 0 | 1 |
Controlledc, n | |||
Yes | 5 | 3 | 2 |
Nod | 8 | 5 | 3 |
UBDRS sub-domain score | |||
Median | 5.5 | 8.0 | 2.5 |
Quartiles [1st;3rd] | [0.0;9.0] | [0.5;9.0] | [0.0;8.1] |
Range [min;max] | [0.0;15.0] | [0.0;15.0] | [0.0;10.0] |
Epileptiform discharges, n | |||
Present | 15 | 9 | 6 |
Not present | 3 | 1 | 2 |
Non-homozygous: include 1-kb deletion compound heterozygous and other genotypes.
A study participant may have more than one seizure type.
Defined as no seizure observed within the year prior to the study visit.
Seizure control was as yet undefined in one compound heterozygous participant (as it was newly onset) and was not included in count.